Effects of Intensive Low-Salt Diet Education by Mobile Application on Albuminuria
NCT03396328 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108
Last updated 2020-09-29
Summary
Albuminuria is a known risk factor for cardiovascular disease (CVD), chronic kidney disease (CKD) progression, all cause mortality. Inhibition of the renin-angiotension-aldosterone system (RAAS) plays an important role in the reduction of albuminuria and preservation of renal function in patients with CKD and it is known that the daily intakes of sodium have a significant effect on the activity of RAAS. Dietary sodium restriction has been shown to enhances the blood pressure, albuminuria, and renal function preservation. Furthermore, recent study has shown that intensive low-salt dietary education reduces albuminuria in patients with CKD. The average sodium intake of Koreans is 4,791 mg/d, which is higher than other countries. It is difficult for medical staff in Korea to invest enough time in low salt diet.
Recently, the development of health-related applications (apps) has been carried out worldwidely, and researches on lifestyle improvement using apps have been actively studied. However, there is no research yet on whether intensive education using an apps can affect lifestyle habits and thus changes in actual new features. Smartphone apps may provide an alternative to resource-intensive low salt diet-education. Therefore, this study aims to investigate the effect of intensive low salt diet training on the changes of albuminuria using application.
Conditions
Interventions
- BEHAVIORAL
-
conventional low salt education
conventional low salt education
- BEHAVIORAL
-
Intensive low salt dietary education by smartphone application
Participants are provided with information on food and recipe, which allows them to record daily meals in their applications. Through the mobile application, the participants receive information on daily salt intake. Based on this information, the clinical nutritionist coach sets a goal for low salt diet and provides feedback to the patients through the mobile application. The clinical nutritionist coach checks the activity of the user more than twice a week and sends in-app messages to maintain compliance.
Sponsors & Collaborators
-
Yonsei University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-05-10
- Primary Completion
- 2020-05-12
- Completion
- 2020-05-12
Countries
- South Korea
Study Locations
More Related Trials
-
Dietary Sodium Restriction in Hemodialysis Patients
NCT01896882 ·Status: UNKNOWN ·Phase: NA
-
Effect of Low Salt and Ckd Progression
NCT05716386 ·Status: COMPLETED ·Phase: NA
-
Lowering Salt Intake in Chronic Kidney Disease: A Pilot Randomized Crossover Trial
NCT00974636 ·Status: COMPLETED ·Phase: NA
-
DIALYSATE SODIUM CONCENTRATION AND BLOOD PRESSURE IN CHRONIC HEMODIALYSIS PATIENTS
NCT06547697 ·Status: COMPLETED ·Phase: NA
-
Sodium-restricted Diets and Symptoms in End Stage Renal Disease: An RCT
NCT02778516 ·Status: COMPLETED ·Phase: NA
-
Effect of Low Versus Standard Dialysate Sodium on 48h Ambulatory BP in Patients With Intradialytic Hypertension
NCT05430438 ·Status: COMPLETED ·Phase: NA
-
The Effects of Lowering Dialysate Sodium in Hypertensive Hemodialysis Patients
NCT01455974 ·Status: COMPLETED ·Phase: NA
-
Haemodialysis Salt Reduction Study
NCT00141609 ·Status: COMPLETED ·Phase: NA
-
SodiUm Restriction by Behavioral Intervention
NCT04805047 ·Status: UNKNOWN ·Phase: NA
-
Ketone Ester and Salt (KEAS) in Young Adults
NCT05545501 ·Status: RECRUITING ·Phase: NA
-
Effect of Sodium Intake on Brain Natriuretic Peptide Levels in Patients With Heart Failure
NCT03351283 ·Status: COMPLETED ·Phase: NA
-
Urea for Chronic Hyponatremia
NCT04588207 ·Status: TERMINATED ·Phase: PHASE2
-
Natriuresis-Guided Diuretic Therapy in Patients With Acute Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease
NCT06203236 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Safety of Dialysate Sodium Individualization in Hemodialysis Patients With Intradialytic Hypotension
NCT00237783 ·Status: TERMINATED ·Phase: PHASE1
-
Treating Metabolic Acidosis in Chronic Kidney Disease to Prevent Adverse Kidney and Cardiovascular Outcomes
NCT06545461 ·Status: COMPLETED ·Phase: NA
-
Effects of Implementing a High Potassium Diet in Heart Failure Patients
NCT03059680 ·Status: COMPLETED ·Phase: NA
-
Ketone Ester And Salt (KEAS) in Older Adults
NCT06868719 ·Status: RECRUITING ·Phase: NA
-
Sodium-Endothelial Function-CKD Study
NCT00141622 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of a Diuretic Algorithm in Clinical Stability in Heart Failure Patients
NCT02068937 ·Status: COMPLETED ·Phase: NA
-
The Effect of Spironolactone on Acute Kidney Injury in Patients Undergoing Coronary Angiography
NCT03329443 ·Status: COMPLETED ·Phase: PHASE2
-
The Diagnostic Performance of 24-hour Urinary Aldosterone for Primary Aldosteronism
NCT06236698 ·Status: COMPLETED
-
Determination of Threshold Values of Aldosterone in HPLC-MS/MS, of Renin and of the Aldosterone / Renin Ratio for the Diagnosis of Primary Hyperaldosteronism
NCT05640128 ·Status: UNKNOWN ·Phase: NA
-
Effects of Spironolactone on Cardio- and Cerebrovascular Morbidity and Mortality in Hemodialysis Patients
NCT01687699 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Hypertonic Sodium Chloride on Urinary Biomarkers in Healthy Subjects and Patients With Chronic Kidney Disease
NCT01623661 ·Status: COMPLETED ·Phase: NA
-
Cardiac Tissue Sodium Assessment in CKD Patients Using Sodium MRI
NCT04848636 ·Status: RECRUITING